March 4, 2014 3:56 pm
With the biopharmaceutical market valued at $70 billion and counting, scientists need every improvement they can get to design and develop these drugs faster and more accurately. A novel technology that will bring synthetic biology to industrial scale promises to dramatically enhance the development pipeline.
March 4, 2014 3:47 pm
In the deadliest breast cancers, a protein driving inflammation fails to shut down, prompting increases in cancer stem cells, according to new research. This new link gives researchers a new potential target for treating triple-negative breast cancer (TNBC). The research indicates that drugs that should potentially be tried on breast cancer patients in clinical trial include over-the-counter anti-inflammatories like aspirin and Naproxen.
January 30, 2014 10:59 am
A cheap, short, at-home Alzheimer’s disease test went so viral the academic website selling it briefly shut down, according to reports. The SAGE test is a community cognitive screening tool, aimed at catching Alzheimer’s earlier and offering a potential cognitive function baseline. Read more...
January 29, 2014 11:09 am
The advantage of solid-phase peptide synthesis (SPPS) this technique is that peptides can be built efficiently with a standard reaction procedure that is well-suited for automation. So what happens during the chiral separation of FMOC-protected amino acids for SPPS, using polysaccharide-based CSPs under reversed-phase (RP) mode? Find out...
January 21, 2014 10:11 am
Safe pharmaceuticals may be the end goal of pharmaceutical QA/QC laboratories, but reliable, accurate and accessible data is what makes that goal possible. When data isn’t collected and organized well, labs become inaccurate and inefficient, which can result in delays– and even product recalls.
January 16, 2014 9:56 am
An East-West team has created a potential anti-pain drug out of a traditional Chinese herbal medicine. The drug appears to be non-addictive, and eases both inflammatory and neuropathic pain. So what's next for the newly discovered compound? Find out...
January 15, 2014 9:27 am
To borrow a line from Robert Frost’s famous poem, for big and small patient populations, two roads are diverging in drug development. Traditional pharmaceutical developers tackle common problems affecting the many; orphan drug and personalized medicine developers target rare problems affecting few people. But which road is more traveled now? Find out...
January 14, 2014 9:32 am
A new gene sequencing approach may give in vitro fertilization (IVF) doctors a potentially less invasive, and more successful, IVF method, according to a new study. The team behind the study believes the new approach may double IVF success rates.
February 5, 2014 9:47 am
The new $650 million Belfer Research Building at the Weill Cornell Medical College will shake up research by offering an entire floor for academics and industry to work elbow-to-elbow in the same labs. Read more...
February 20, 2014 9:45 am
Bone marrow transplants are the only potential cure for many blood cancers in older patients, but many in this group are ruled ineligible because the procedure is often deemed too harsh for older people. Since more than half of AML patients are over 65 years old, new tactics to prepare these patients for hematopoietic stem cell transplantation are needed.